Trial Condition(s):
Study to assess safety of a hormone therapy preparation containing Drospirenone/Estradiol in women with concomitant disease and medication known to potentate the risk of hyperkalemia
91052
Not Available
Not Available
Not Available
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations |
---|
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety of the Hormone Replacement Therapy Combination Drug Product Drospirenone/Estradiol in Postmenopausal Women With Concomitant Disease and Medication Known to Potentiate the Risk of Hyperkalemia
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A